Surface Modification of Biomaterials: A Quest for Blood Compatibility

Cardiovascular implants must resist thrombosis and intimal hyperplasia to maintain patency. These implants when in contact with blood face a challenge to oppose the natural coagulation process that becomes activated. Surface protein adsorption and their relevant 3D confirmation greatly determine the...

Full description

Bibliographic Details
Main Authors: Achala de Mel, Brian G. Cousins, Alexander M. Seifalian
Format: Article
Language:English
Published: Hindawi Limited 2012-01-01
Series:International Journal of Biomaterials
Online Access:http://dx.doi.org/10.1155/2012/707863
id doaj-7d13fb1767be4e48a73a0bdeca3936e0
record_format Article
spelling doaj-7d13fb1767be4e48a73a0bdeca3936e02020-11-24T22:08:54ZengHindawi LimitedInternational Journal of Biomaterials1687-87871687-87952012-01-01201210.1155/2012/707863707863Surface Modification of Biomaterials: A Quest for Blood CompatibilityAchala de Mel0Brian G. Cousins1Alexander M. Seifalian2UCL Centre for Nanotechnology & Regenerative Medicine, University College London, Pond Street, London NW3 2QG, UKUCL Centre for Nanotechnology & Regenerative Medicine, University College London, Pond Street, London NW3 2QG, UKUCL Centre for Nanotechnology & Regenerative Medicine, University College London, Pond Street, London NW3 2QG, UKCardiovascular implants must resist thrombosis and intimal hyperplasia to maintain patency. These implants when in contact with blood face a challenge to oppose the natural coagulation process that becomes activated. Surface protein adsorption and their relevant 3D confirmation greatly determine the degree of blood compatibility. A great deal of research efforts are attributed towards realising such a surface, which comprise of a range of methods on surface modification. Surface modification methods can be broadly categorized as physicochemical modifications and biological modifications. These modifications aim to modulate platelet responses directly through modulation of thrombogenic proteins or by inducing antithrombogenic biomolecules that can be biofunctionalised onto surfaces or through inducing an active endothelium. Nanotechnology is recognising a great role in such surface modification of cardiovascular implants through biofunctionalisation of polymers and peptides in nanocomposites and through nanofabrication of polymers which will pave the way for finding a closer blood match through haemostasis when developing cardiovascular implants with a greater degree of patency.http://dx.doi.org/10.1155/2012/707863
collection DOAJ
language English
format Article
sources DOAJ
author Achala de Mel
Brian G. Cousins
Alexander M. Seifalian
spellingShingle Achala de Mel
Brian G. Cousins
Alexander M. Seifalian
Surface Modification of Biomaterials: A Quest for Blood Compatibility
International Journal of Biomaterials
author_facet Achala de Mel
Brian G. Cousins
Alexander M. Seifalian
author_sort Achala de Mel
title Surface Modification of Biomaterials: A Quest for Blood Compatibility
title_short Surface Modification of Biomaterials: A Quest for Blood Compatibility
title_full Surface Modification of Biomaterials: A Quest for Blood Compatibility
title_fullStr Surface Modification of Biomaterials: A Quest for Blood Compatibility
title_full_unstemmed Surface Modification of Biomaterials: A Quest for Blood Compatibility
title_sort surface modification of biomaterials: a quest for blood compatibility
publisher Hindawi Limited
series International Journal of Biomaterials
issn 1687-8787
1687-8795
publishDate 2012-01-01
description Cardiovascular implants must resist thrombosis and intimal hyperplasia to maintain patency. These implants when in contact with blood face a challenge to oppose the natural coagulation process that becomes activated. Surface protein adsorption and their relevant 3D confirmation greatly determine the degree of blood compatibility. A great deal of research efforts are attributed towards realising such a surface, which comprise of a range of methods on surface modification. Surface modification methods can be broadly categorized as physicochemical modifications and biological modifications. These modifications aim to modulate platelet responses directly through modulation of thrombogenic proteins or by inducing antithrombogenic biomolecules that can be biofunctionalised onto surfaces or through inducing an active endothelium. Nanotechnology is recognising a great role in such surface modification of cardiovascular implants through biofunctionalisation of polymers and peptides in nanocomposites and through nanofabrication of polymers which will pave the way for finding a closer blood match through haemostasis when developing cardiovascular implants with a greater degree of patency.
url http://dx.doi.org/10.1155/2012/707863
work_keys_str_mv AT achalademel surfacemodificationofbiomaterialsaquestforbloodcompatibility
AT briangcousins surfacemodificationofbiomaterialsaquestforbloodcompatibility
AT alexandermseifalian surfacemodificationofbiomaterialsaquestforbloodcompatibility
_version_ 1725813942828138496